Background. Previous studies have suggested that fluoroquinolone-resistant strains of Escherichia coli that infect humans probably emerged as a consequence of using fluoroquinolones in poultry. This study aims to provide further insight into the possible avian origin of fluoroquinolone-resistant extraintestinal pathogenic E. coli (ExPEC) strains that infect humans.
Human extraintestinal infections caused by Escherichia coli, including urinary tract infections (UTIs), sepsis, and neonatal meningitis, are very common and represent an emerging public health concern [1, 2, 3] . The E. coli strains associated with these infections usually possess peculiar virulence traits and are known as extraintestinal pathogenic E. coli (ExPEC) [2, 4] . Extraintestinal E. coli infection is also common in farm animals, in which it is referred to as systemic colibacillosis [5] . In the poultry industry worldwide, colibacillosis represents an important cause of disease and economic loss [6, 7, 8] . The E. coli strains associated with colibacillosis in poultry are known as avian pathogenic E. coli (APEC).
For both ExPEC and APEC strains, a broad range of virulence factors have been described that confer the ability to overcome host defenses, invade host tissues, and cause extraintestinal disease [9, 10] . These virulence factors may be present in different combinations from strain to strain and include serum resistance and temperature-sensitive hemagglutination as well as the production of adhesins, aerobactin, toxins, iron-acquisition factors, and colicin V. Although ExPEC strains are usually considered to be host adapted, similar arrays of virulence factors may be shared by isolates from different animal species [11, 12] .
Fluoroquinolones (FQs) are considered the drug of choice for the treatment of ExPEC infections [13] , and the recently observed increase in the number of FQ-resistant strains is an alarming public health concern [14, 15] . FQs are also widely used in farm animals, mainly in poultry, and FQ-resistant E. coli strains are frequently isolated from healthy and diseased birds [8] . Therefore, it has been suggested that the emergence and dissemination of FQ-resistant E. coli strains that infect humans is a consequence of the intensive use of these drugs in poultry farming [16 -19] . FQ-resistant strains may contaminate poultry by-products and be acquired by human beings via the food supply. The results of a recent study performed by Johnson et al. [17] supported the hypothesis that the FQ-resistant E. coli strains recovered from humans have an avian origin, because multiple molecular typing analysis showed these strains to be similar to both FQ-susceptible and FQ-resistant isolates recovered from chickens but distinct from FQ-susceptible isolates recovered from humans. However, we agree with the results reported by Collignon et al. [16] and feel that further investigations of E. coli isolates from different countries are needed. To our knowledge, no data concerning this issue have been reported in the literature on E. coli strains recovered in Italy. With the aim of providing further insight into the possible avian origin of FQ-resistant Ex-PEC strains that infect humans, we compared the phylogenetic backgrounds and virulence gene profiles of ciprofloxacinsusceptible and ciprofloxacin-resistant E. coli strains isolated from human extraintestinal infections and from chickens and turkeys; the avian strains were recovered either from birds with colibacillosis or at slaughter.
MATERIALS AND METHODS
Bacterial strains. A total of 238 E. coli strains were included in this study. There were 82 strains recovered from individuals with UTI (41 ciprofloxacin-susceptible and 41 ciprofloxacinresistant strains), 43 strains recovered from individuals with sepsis (20 ciprofloxacin-susceptible and 23 ciprofloxacinresistant strains), 74 strains recovered from chickens and turkeys with colibacillosis (26 ciprofloxacin-susceptible and 48 ciprofloxacin-resistant strains), and 39 strains recovered from chickens and turkeys at slaughter (21 ciprofloxacin-susceptible and 18 ciprofloxacin-resistant strains). The human E. coli strains were collected between January and December 2006; those recovered from individuals with UTI were collected from outpatients who presented to the BIOS Diagnostic Laboratory (Rome, Italy), and those recovered from individuals with sepsis were collected from patients admitted to San Camillo Forlanini Hospital (Rome, Italy). The avian E. coli strains were recovered from For each strain, ciprofloxacin susceptibility was confirmed by use of the E-Test (AB-Biodisk) on Mueller-Hinton agar plates (Oxoid), in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines [20] . CLSI breakpoints were used to interpret the results. E. coli ATCC 25922 and ATCC 35218 were used as control strains.
Phylogenetic typing and virulence genotyping. All strains were assigned to 1 of the 4 major E. coli phylogenetic groups (A, B1, B2, and D) by use of the multiplex polymerase chain reaction (PCR)-based method described by Clermont et al. [21] . Moreover, each strain was examined for the presence of 12 virulence genes (table 1) known for their association with pathogenicity in APEC or human ExPEC strains, by use of PCR. This panel of genes included toxin genes, such as cnf1 (cytotoxic necrotizing factor 1) and cdt (cytolethal distending toxin); genes encoding protectins, such as cvaC (colicin V operon), traT (outer membrane protein), and iss (serum resistance); siderophore-related genes, such as ireA (iron-responsive element), iroN (catecholate siderophore receptor), iucD (aerobactin synthesis), and iutA (ferric aerobactin receptor); and genes associated with bacterial adhesion, such as agg (enteroaggregative adhesion), eae (outer membrane protein intimin), and tsh (temperature-sensitive hemagglutinin) [6, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . Total DNA extracts were prepared by use of a rapid boiling method. Amplification was performed in a 50-L reaction mixture containing 30 pmol of each primer; CDT F and CDT R cdt 469 [25] traT F and traT R traT 290 [26] cvaC F and cvaC R cvaC 680 [27] iroN F and iroN R iroN 665 [28] iutA F and iutA R iutA 302 [27] Iss F and Iss R iss 607 [29] iucD F and iucD R iucD 760 [30] tsh F and tsh R tsh 640 [31] ireA F and ireA R ireA 254 [6] chuA R and chuA F chuA 279 [21] yjaA R and yjaA F yjaA 211 [21] DNA fragment TspE4.C2 R and TspE4.C2 F TspE4.C2 152 [21] NOTE. F, forward; R, reverse.
PCR buffer containing 1.5 mmol/L MgCl 2 , 0.2 mmol/L dNTP mixture, 1 U GoTaq DNA polymerase (Promega); and 10 L template DNA. In both virulence genotyping and phylogenetic analysis, appropriate positive and negative controls were included in each PCR amplification run. Pulsed-field gel electrophoresis (PFGE). Genetic relatedness among the 39 strains that belonged to the major virulence profile (i.e., the traT-iucD-iutA profile) was assessed by use of PFGE after digestion of DNA with XbaI and following procedures described elsewhere [32] . Salmonella enterica serovar Braenderup H9812 was used as the molecular size marker in the PFGE experiment [33] 
RESULTS
Phylogenetic typing. The distribution of E. coli strains with respect to the 4 phylogenetic groups is shown in table 2. Overall, the phylogenetic assignment of human and avian strains differed significantly for 3 of the 4 groups (namely B1, B2, and D). Similar to results obtained in previous studies, the majority of our virulent human strains were associated with group B2 (61 [48.8%] of 125) [34, 35] , whereas avian strains predominantly fell into group D (46 [41.8%] of 113) [35] . Among human strains, no significant difference was observed between ciprofloxacin-susceptible and ciprofloxacin-resistant strains with respect to group distribution. Conversely, ciprofloxacinsusceptible avian strains were found to belong to phylogenetic group B2 more frequently than were ciprofloxacin-resistant avian strains. It is worth noting that the phylogenetic backgrounds of ciprofloxacin-resistant strains from human and avian sources were strongly dissimilar; human and avian strains differed significantly with respect to the proportion of strains assigned to each phylogenetic group for 3 of the 4 groups.
Virulence genotyping. The prevalence of virulence genes among the E. coli strains, stratified by source and by ciprofloxacin susceptibility or resistance, is shown in table 2. The strains of E. coli recovered from individuals with UTI (n ϭ 82) and individuals with sepsis (n ϭ 43) were combined for comparison with the avian strains because the human strains did not differ significantly with respect to the prevalence of virulence genes other than cvaC (P ϭ .05) and iroN (P ϭ .008). Avian strains were combined for comparison in a similar way because the strains recovered from birds with colibacillosis (n ϭ 74) and those from slaughtered animals (n ϭ 39) did not differ significantly with respect to the prevalence of virulence genes other than cvaC (P Ͻ .001) and tsh (P ϭ .003).
Overall, genes that encode virulence factors associated with tissue invasion, such as protectins (cvaC, traT, and iss) and siderophore-related proteins (iucD, iutA, ireA and iroN), occurred frequently among the strains we analyzed, although the percentage of human strains in which they occurred differed from the percentage of avian strains in which they occurred (table 2). No strains harbored genes associated with intestinal adhesion (agg or eae), whereas the tsh gene occurred frequently among avian strains but not among human strains ( When the strains were grouped according to ciprofloxacin susceptibility and resistance, we found that susceptible human and avian strains differed significantly with respect to the prevalence of the following 7 virulence genes: cnf1, cvaC, iroN, iss, iucD, iutA, and tsh. All except cnf1 were more prevalent among susceptible avian strains. This result is not surprising, because these genes are associated with plasmid pTJ100, which has frequently been observed in APEC strains [6] . When the ciprofloxacin-resistant strains were considered, we observed a significant difference between human and avian strains with respect to the following 5 virulence genes: iroN, iss, and tsh were more common among avian strains, whereas iucD and iutA were more prevalent among human strains.
When ciprofloxacin-susceptible and ciprofloxacin-resistant strains from the same source were compared, we found that resistant strains of both human and avian origin harbored fewer virulence genes than did susceptible strains. Among human strains, ireA, iroN, cnf1, and cdt were significantly more common or even exclusively present in susceptible strains, whereas iucD and iutA appeared to be associated with resistant strains. This observation is in agreement with the results of previous studies demonstrating that iutA showed a significant shift towards the phenotype of resistance in human ExPEC strains [36, 37] . Conversely, among avian strains the same 2 genes (iucD and iutA) were significantly more common in susceptible strains than in resistant strains.
Virulence gene profiles. One hundred ten (88.0%) of 125 human strains and 108 (95.6%) of 113 avian strains showed the presence of 1 of the virulence genes we tested. The virulence gene profiles we observed are shown in table 3. Generally, avian strains exhibited a greater heterogeneity of virulence profiles than did human strains. Among human strains, 31 distinct virulence gene profiles were found but 50 strains (40.0%) belonged to either the traT-iucD-iutA (34 [27.2%]) profile or the iucDiutA (16 [12. 8%]) profile. Together, these 2 major profiles accounted for 42 (65.6%) of 64 human ciprofloxacin-resistant strains but for only 8 (13.1%) of 61 human ciprofloxacinsusceptible strains, which were more widely distributed among Table 2 . Prevalence of virulence genes and phylogenetic group distribution for 238 Escherichia coli strains recovered from both humans and avian species. 34) , whereas all 6 avian strains belonged to group A. With respect to strains that belonged to the iucD-iutA profile (16 human strains and 2 avian strains), human strains belonged to group A (5 strains), group B2 (5 strains), and group D (6 strains), whereas the 2 avian strains fell into groups A and D, respectively. The finding that strains sharing the same virulence profile can belong to different phylogenetic groups suggests some kind of virulence gene mobility among different E. coli strains. PFGE analysis. Since the traT-iucD-iutA profile, a major profile among human ciprofloxacin-resistant strains, was also observed in avian ciprofloxacin-resistant strains, we investigated the genetic relationships among all the E. coli strains that belonged to that profile. A total of 40 strains were included, 34 human strains (6 susceptible and 28 resistant to ciprofloxacin) and 6 avian strains (all resistant to ciprofloxacin).
Among these 40 strains, 39 distinct restriction patterns were observed, although 1 strain was not typeable by PFGE ( figure 1) . A close genetic relationship (coefficient of similarity, 80%) was observed among 17 human strains (cluster A in figure 1 ), including 16 ciprofloxacin-resistant strains and 1 ciprofloxacinsusceptible strain. Other minor clusters, each containing 2 or 3 strains recovered from humans, were observed (clusters B, C, E, and F in figure 1 ), whereas 6 of the human strains were totally unrelated to each other (coefficient of similarity, Ͻ80%). Remarkably, the 6 avian strains were totally unrelated to both susceptible and resistant human strains. Two of these 6 avian strains were closely related to each other (cluster D in figure 1 ), whereas the remaining 4 showed no genetic relatedness. Overall, the PFGE clusters matched phylogenetic group assignment (i.e., strains belonging to the same cluster belonged to the same phylogenetic group). It is worth noting that all the strains included in the major PFGE cluster A belonged to the phylogenetic group B2 (figure 1).
DISCUSSION
There is currently debate about whether the emergence and dissemination of FQ resistance among E. coli strains that infect humans is a consequence of FQ use in food animals [16, [17] [18] [19] .
To provide further insight into this topic, we compared the phylogenetic backgrounds and the virulence gene profiles of ciprofloxacin-susceptible and ciprofloxacin-resistant E. coli strains isolated from both human extraintestinal infections and poultry. Phylogenetic typing supported the hypothesis that the ciprofloxacin-resistant human ExPEC strains we analyzed were clearly distinct from ciprofloxacin-resistant avian strains (there was a significant difference with respect to the proportion of strains assigned to each phylogenetic group for 3 of the 4 groups). The human ExPEC strains described herein belonged mainly to group B2, irrespective of whether they were resistant or susceptible to ciprofloxacin. In contrast with data reported in other studies, the human strains we studied did not exhibit a marked shift away from the phylogenetic group B2 toward groups A, D, or B1 in association with ciprofloxacin resistance [17, [37] [38] [39] . Although some increase in the number of strains assigned to group A was observed among ciprofloxacin-resistant human strains, it was not statistically significant. Conversely, among avian strains, fewer resistant strains than susceptible strains belonged to group B2 (13 [27.1%] vs. 6 [9.7%]; P ϭ .02).
In addition, a panel of virulence genes known to be associated with APEC strains and/or human ExPEC strains was chosen to be used in virulence typing [6, 27] . Irrespective of ciprofloxacin resistance or susceptibility, the comparison of human and avian Figure 1 . Genetic relatedness among 39 Escherichia coli strains with the major virulence profile traT-iucD-iutA was assessed by cluster analysis of pulsed-field gel electrophoresis (PFGE) patterns (PFGE was performed after digestion of DNA with XbaI). The column on the right reports the strain code number, source, clinical condition of the source, and phylogenetic group assignment. Similarity analysis was performed with Dice's coefficient and clustering by the unweighted pair group method with arithmetic averages. Strains with a coefficient of similarity value 80% were considered to belong to the same clonal group (groups are in boxes).
strains demonstrated that virulence genes were less prevalent among human ExPEC strains than among avian strains, based on the panel we used. The only exception was the cnf1 gene, which occurred most frequently among human strains, a result that agrees with data previously reported [6, 17, 40] . Stratification by ciprofloxacin susceptibility status showed that ciprofloxacin-susceptible human strains were distinct from ciprofloxacin-susceptible avian strains with respect to their virulence genes (there was a significant difference in the distribution of 7 virulence genes), and ciprofloxacin-resistant human strains were also distinct from ciprofloxacin-resistant avian strains in this regard, although to a lesser extent (there was a significant difference in the distribution of 5 virulence genes).
To investigate possible differences due to the site from which of human ExPEC strains were recovered (i.e., blood or urine), we separately compared resistant avian strains with resistant human strains recovered from individuals with UTI and resistant human strains recovered from individuals with sepsis, but we again found that in both comparisons, resistant human strains differed significantly from resistant avian strains with respect to 5 virulence genes. It is worth noting that ciprofloxacin-resistant strains generally possessed fewer virulence genes than both human and avian ciprofloxacin-susceptible strains. This finding confirms previous data demonstrating that, for uropathogenic ExPEC, resistance to quinolones is associated with a lower prevalence of some virulence genes, including those located in pathogenicity islands [39, [41] [42] [43] [44] .
In the literature, substantial debate has recently arisen about whether the marked reduction in virulence associated with FQ resistance precedes or follows the acquisition of such resistance. Some suggest that bacterial subpopulations of ExPEC with intrinsic reduced virulence and a phylogenetic background other than B2 acquire FQ resistance [38, 39, 42] , while others suggest that FQ-resistant ExPEC strains are simply mutant derivatives of the susceptible strains, quinolones being able to induce partial or total loss of pathogenicity islands in ExPEC strains that belong to phylogenetic group B2 [44, 45] . Although the present study did not focus on clarifying this important issue, our data seem to suggest a more complex scenario. First, the phylogenetic background of the susceptible and resistant human strains that we analyzed is not different. Second, the resistant human strains lacked the cnf1, ireA, and iroN genes but showed an increased prevalence of iutA and iucD, which were both included in the 2 major virulence profiles, traT-iucD-iutA and iucD-iutA. In accord with the results of a previous study [36] , we can speculate that, among human ExPEC strains, FQ resistance may require a particular genetic background that does not necessarily correspond to the phylogenetic background. The situation is slightly different in avian strains, in which the genetic background might partially match the phylogenetic background, at least in some cases, because in these strains a shift away from the phylogenetic group B2 was observed in association with ciprofloxacin resistance. However, group B2 was not the most common phylogenetic group even among susceptible avian strains, and the distribution of strains in phylogenetic groups other than B2 was not significantly different for resistant and susceptible avian strains.
As far as the virulence gene profiles are concerned, it is interesting to note that the traT-iucD-iutA profile, which was observed in almost half the human ciprofloxacin-resistant strains, was shared with some ciprofloxacin-resistant avian strains. On the basis of this finding, the hypothesis that a large number of human ciprofloxacin-resistant strains might have been derived from a subgroup of ciprofloxacin-resistant avian strains could not be ruled out. To investigate this hypothesis, the genetic relationships among human and avian E. coli strains that belonged to the traT-iucD-iutA virulence profile were assessed by PFGE. Although a major cluster and some other minor clusters were identified, no overlap was found between the genotypes of the avian strains and those of either ciprofloxacin-susceptible or ciprofloxacin-resistant human strains. These results do not support the suggestion that the human ciprofloxacin-resistant strains described in the present study have an avian origin. With respect to the major cluster of human strains (cluster A), it is interesting to note that it included all but 1 of the ciprofloxacinresistant strains that belonged to phylogenetic group B2. Identification of such a large cluster is also remarkable in view of the recent emergence of E. coli clonal group ST 131 as a multidrugresistant human pathogen [46] . Further studies, are in progress to investigate dissemination of this clone among the human ExPEC strains we analyzed.
In the study carried out by Johnson et al. [17] , a substantial overlap was found between ciprofloxacin-resistant isolates recovered from humans and both ciprofloxacin-susceptible and ciprofloxacin-resistant isolates recovered from chickens with respect to their virulence profiles and phylogenetic distribution, suggesting that chicken products may be a source for potentially pathogenic FQ-resistant E. coli in humans. The data from the present study did not support this suggestion. The ciprofloxacin-resistant human strains analyzed in this study very likely did not derive from an avian source because, as detailed above, our ciprofloxacin-resistant human ExPEC strains were clearly distinct (with respect to both virulence gene content and phylogenetic background) from both ciprofloxacin-susceptible and ciprofloxacin-resistant avian strains. Possible explanations for the disagreement between our study results and those of Johnson et al. include the different human E. coli isolates or strains chosen for analysis and the panel of virulence genes used. Additional potential explanations, such as geographic setting (our study was done in Italy, whereas theirs was done in Spain) and time frame (our study used strains collected in 2006, whereas theirs used isolates obtained during 1996 -1998), cannot be ruled out. However, since a more recent study conducted in the United States confirmed the hypothesis of possible avian origin for many drug-resistant human E. coli strains [40] , factors other than geography and time period may likely play a major role. As far as the human E. coli strains chosen for analysis are concerned, the Spanish study analyzed a collection of human E. coli isolates obtained from both the intestinal tract of human volunteers (i.e., normal flora) and the blood of patients with sepsis [17] , the American survey examined human E. coli isolates from fecal samples that were categorized as ExPEC on the basis of the virulence genes they exhibited [40] , whereas the human strains we tested were recovered exclusively from individuals with UTI or sepsis. Regarding the choice of virulence traits to be tested, both the Spanish and American studies used a panel of genes that included several ExPEC-associated virulence genes, which are known to be more prevalent among human isolates than among avian isolates. Our panel was more avian oriented, because 7 of 12 virulence genes (cvaC, iutA, traT, iss, iucD, tsh and iroN ) were pTJ100-associated genes, a group of plasmidrelated genes that occur in the majority of APEC strains [10] . On the basis of these considerations, the importance of the choice of the virulence traits assessed when attempting to detect differences between human and avian isolates should be emphasized.
A limitation of the present study is that E. coli strains from both human and avian species were only obtained from 2 geographical locations. However, avian E. coli strains were recovered through the diagnostic and surveillance activities of the Istituto Zooprofilattico delle Venezie in a region that hosts the greatest number of avian farms in Italy, from which poultry is sold all over the country. As far as human ExPEC strains are concerned, although strains recovered from blood were obtained from patients with sepsis in a single hospital, uropathogenic strains were recovered from outpatients.
In conclusion, previous studies suggest that FQ-resistant E. coli strains in humans emerged as a consequence of FQ use in food animals, but no evidence to support this assumption was found in this study, since resistant ExPEC strains from humans were found to be clearly distinct from both resistant and susceptible avian strains. It might be speculated that, although FQresistant E. coli strains might be acquired by humans via the food supply, these strains may not be the source of E. coli capable of causing extraintestinal disease. However, because of the risk to human health resulting from selection for FQ-resistant E. coli in food animals and considering the recent emergence of plasmidmediated quinolone resistance mechanisms that result in the potential transfer of resistance genes between animals and humans [47] , prudent use of FQs in both human and veterinary medicine should be recommended.
